Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants


Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
Toxidromes: Clinical Features01:30

Toxidromes: Clinical Features

Toxidromes are specific patterns of symptoms resulting from toxic substance exposure. They help in the identification and treatment of poisoning. The symptoms of each toxidrome group indicate poisoning by a certain class of chemicals or drugs.1. Sympathomimetic: Stimulates the sympathetic nervous system. Symptoms include agitation, increased heart rate (HR), blood pressure (BP), respiratory rate (RR), temperature, and pupil size. Drugs like cocaine and amphetamines, along with tremors and...
Anxiety: Overview01:18

Anxiety: Overview

Anxiety is a common mental disorder featuring excessive worry, fear, and apprehension, significantly affecting daily life. People with anxiety disorders experience persistent and intense anxiety, interrupting their everyday functioning.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Bulimia Nervosa01:30

Bulimia Nervosa

Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Energy Drink Use in Adolescents With and Without ADHD: Trends and Influences.

Innovations in clinical neuroscience·2022
Same author

Environmental risk factors, protective factors, and peripheral biomarkers for ADHD: an umbrella review.

The lancet. Psychiatry·2020
Same author

Genetic Variation and Autism: A Field Synopsis and Systematic Meta-Analysis.

Brain sciences·2020
Same author

Environmental risk factors and biomarkers for autism spectrum disorder: an umbrella review of the evidence.

The lancet. Psychiatry·2019
Same author

Association Between Antidepressants Use During Pregnancy and Autistic Spectrum Disorders: A Meta-analysis.

Innovations in clinical neuroscience·2014
Same author

Helping the angels: a review of understanding and helping dying children.

Innovations in clinical neuroscience·2013

Related Experiment Video

Updated: May 7, 2026

Transcranial Direct Current Stimulation for Online Gamers
06:01

Transcranial Direct Current Stimulation for Online Gamers

Published on: November 9, 2019

Adderall-induced Trichotillomania: A Case Report.

Chiranjir Narine1, Sajjad R Sarwar, Theodor B Rais

  • 1Dr. Narine is a resident of psychiatry, Dr. Sarwar is fellow of child and adolescent psychiatry, and Dr. Rais is the associate professor and program director of the Department of Child and Adolescent Psychiatry-All from the University of Toledo, Toledo, Ohio.

Innovations in Clinical Neuroscience
|September 25, 2013
PubMed
Summary
This summary is machine-generated.

This case study highlights an unusual side effect of Adderall (dextroamphetamine/amphetamine). A 12-year-old girl developed trichotillomania after starting the medication for attention deficit hyperactivity disorder.

Keywords:
ADHDAdderallattention deficit hyperactivity disordertrichotillomania

More Related Videos

Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder
11:17

Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder

Published on: November 25, 2025

Assessing Activity-based Anorexia in Mice
08:26

Assessing Activity-based Anorexia in Mice

Published on: May 14, 2018

Related Experiment Videos

Last Updated: May 7, 2026

Transcranial Direct Current Stimulation for Online Gamers
06:01

Transcranial Direct Current Stimulation for Online Gamers

Published on: November 9, 2019

Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder
11:17

Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder

Published on: November 25, 2025

Assessing Activity-based Anorexia in Mice
08:26

Assessing Activity-based Anorexia in Mice

Published on: May 14, 2018

Area of Science:

  • Psychiatry
  • Pharmacology
  • Pediatrics

Background:

  • Adderall (dextroamphetamine/amphetamine) is a common psychostimulant for attention deficit hyperactivity disorder (ADHD).
  • It is generally well-tolerated with few side effects.

Purpose of the Study:

  • To report a rare case of trichotillomania potentially induced by Adderall in a pediatric patient.
  • To investigate the relationship between stimulant medication and the development of hair-pulling disorder.

Main Methods:

  • A case report of a 12-year-old female diagnosed with ADHD.
  • Observation of new-onset trichotillomania following initiation of Adderall therapy.
  • Discontinuation of Adderall and initiation of guanfacine.
  • Clinical follow-up for over one year.

Main Results:

  • The patient developed trichotillomania shortly after starting Adderall.
  • Discontinuation of Adderall and switching to guanfacine resulted in the resolution of hair-pulling behavior and anxiety.
  • No recurrence of trichotillomania was observed during the follow-up period.

Conclusions:

  • Adderall may be associated with the development of trichotillomania, an uncommon side effect.
  • Guanfacine may be an effective alternative treatment for ADHD in patients experiencing stimulant-induced side effects.
  • Further research is needed to explore the neurobiological mechanisms linking stimulants to trichotillomania.